You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

Article metrics

Article menu

This article has a correction. Please see:

Immunotherapy biomarkers
Original research
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2025

AbstractFullPdf
Nov 2022843851377
Dec 2022448454157
Jan 202325525774
Feb 2023258262107
Mar 2023209209101
Apr 202314514952
May 202315215471
Jun 202311511658
Jul 202313413578
Aug 202312312566
Sep 202319719882
Oct 202330931185
Nov 202316116271
Dec 2023949473
Jan 202410911182
Feb 2024888865
Mar 2024111112124
Apr 2024676766
May 2024747561
Jun 2024706947
Jul 202410610970
Aug 20241009847
Sep 202412012079
Oct 202411211260
Nov 20249810052
Dec 202422322994
Jan 202512612677
Feb 202533533681
Mar 2025177182117
Apr 202519019184
May 202513113351
Jun 202514214448
Jul 2025110
Oct 2025220
Nov 2025880
Total583358902757